Modern Targeted Treatment Strategies in CLL

In part 2 of a Blood Cancers Today roundtable discussion, moderator Tycel Phillips, MD, of City of Hope, leads a discussion with Danielle Brander, MD of Duke Cancer Institute, Erin Mulvey, MD of Weill Cornell Medicine, Seema Bhat, MD of The Ohio State University Comprehensive Cancer Center, and Andres Chang, MD, PhD of Emory University School of Medicine on the evolving treatment landscape for chronic lymphocytic leukemia (CLL), with a focus on combining BTK inhibitors and BCL-2 inhibitors across lines of therapy. Watch more ASH 2025 roundtable discussion at www.bloodcancerstoday.com.